Literature DB >> 8018749

Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.

H E Heslop, M K Brenner, C Rooney, R A Krance, W M Roberts, R Rochester, C A Smith, V Turner, J Sixbey, R Moen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8018749     DOI： 10.1089/hum.1994.5.3-381

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  15 in total

1.  CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma.

Authors:  J P Christensen; R D Cardin; K C Branum; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex).

Authors:  Juan F Vera; Lara J Brenner; Ulrike Gerdemann; Minhtran C Ngo; Uluhan Sili; Hao Liu; John Wilson; Gianpietro Dotti; Helen E Heslop; Ann M Leen; Cliona M Rooney
Journal:  J Immunother       Date:  2010-04       Impact factor: 4.456

3.  Targeting cytomegalovirus-infected cells using T cells armed with anti-CD3 × anti-CMV bispecific antibody.

Authors:  Lawrence G Lum; Mayur Ramesh; Archana Thakur; Subhashis Mitra; Abhinav Deol; Joseph P Uberti; Philip E Pellett
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-05       Impact factor: 5.742

Review 4.  Gene therapy for infectious diseases.

Authors:  B A Bunnell; R A Morgan
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope.

Authors:  P G Stevenson; G T Belz; M R Castrucci; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

6.  Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders.

Authors:  M A Nalesnik; A Zeevi; P S Randhawa; A Faro; K J Spichty; A J Demetris; J J Fung; T L Whiteside; T E Starzl
Journal:  Clin Transplant       Date:  1999-02       Impact factor: 2.863

Review 7.  NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.

Authors:  Edwin P Alyea; Daniel J DeAngelo; Jeffrey Moldrem; John M Pagel; Donna Przepiorka; Michel Sadelin; James W Young; Sergio Giralt; Michael Bishop; Stan Riddell
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-24       Impact factor: 5.742

Review 8.  T cell immunotherapeutic populations control viral infections in bone marrow transplant recipients.

Authors:  K S Slobod; E Benaim; L Woodruff; S Nooner; J Houston; M Holladay; T Lockey; J L Hurwitz
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

9.  Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

Authors:  R Khanna; S Bell; M Sherritt; A Galbraith; S R Burrows; L Rafter; B Clarke; R Slaughter; M C Falk; J Douglass; T Williams; S L Elliott; D J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

10.  T cell receptor repertoire of CD4+ and CD8+ T cell subsets in the allogeneic bone marrow transplant recipient.

Authors:  F S Smith; S D Rencher; H E Heslop; J L Hurwitz
Journal:  Cancer Immunol Immunother       Date:  1995-08       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.